More and more drugmakers are giving continuous manufacturing a try, seeing it as the future in small molecule drug production, in part, because the plants for the process are much smaller than those ...

A handful of companies have done pioneering work with continuous manufacturing, the production process that is faster, cheaper and less prone to the kinds of manufacturing mess-ups that worry the FDA.

Continuous manufacturing makes monoclonal antibody production faster, cheaper, and greener, say researchers, who predict that industry adoption of the approach will accelerate in response to ...

The pharmaceutical industry has been slow to adopt a business practice that is faster, safer, and more efficient than its current way of operating; that the FDA has been encouraging the industry to ...

DIANT is a startup co-founded by Antonio Costa, Ph.D. and Diane Burgess, Ph.D. In 2020, DIANT licensed their core manufacturing technology from UConn and was granted a patent on the technology earlier ...

Although estimates vary slightly, many industry experts predict continuous manufacturing will, at the least, cut the cost of manufacturing biologics in half. Thus, it will be an attractive option for ...

One of the first digital manufacturing facilities in the world to use continuous, intensified biologics production technology Framingham, Massachusetts facility will manufacture biologics for the ...

The biopharmaceutical industry has seen substantial growth in recent years, generating novel biotherapeutics and biosimilars at an unprecedented rate. One of the biggest challenges in the industry is ...

This workshop will discussed the business and regulatory concerns associated with adopting continuous manufacturing techniques to produce biologics, such as enzymes, monoclonal antibodies, and ...

COEUR D’ALENE, Idaho--(BUSINESS WIRE)--Continuous Composites announced their opening of a 7,500 sq-foot facility for research, development, and additive manufacturing in Coeur d'Alene, Idaho. The new ...